Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey MedStar authors:
- Hall, Jordan
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
All authors: - Orquiza M, Hall J, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
- Atkins, Frank
- Khorjekar, Gauri
- Orquiza, Michael D
- Van Nostrand, Douglas
Year: 2013
Department: - Department of Medicine/Nuclear Medicine
All authors: - Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G
|
|
17.
|
|
|
18.
|
|
|
19.
|
|
|
20.
|
Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors:
- Hall, Jordan
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
All authors: - Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
|
|
21.
|
|
|
22.
|
|
|
23.
|
Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors:
- Hall, Jordan
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
Year: 2013
Institution:
- MedStar Washington Hospital Center
-
Department: - Medicine/Nuclear Medicine
All authors: - Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
|
|
24.
|
The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
25.
|
The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
26.
|
Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors:
- Atkins, Frank
- Garcia, Carlos
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Medicine/Nuclear Medicine
All authors: - Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
|
|
27.
|
Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors:
- Bethancourt, Evelyn
- Bikas, Athanasios
- Burman, Kenneth D
- Orquiza, Michael
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
Year: 2019
Citation: - Journal of Nuclear Medicine. 60(5):638-643, 2019 05.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
Medline publication type:
All authors: - Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D
|
|
28.
|
Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors:
- Atkins, Frank
- Garcia, Carlos
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
All authors: - Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D
|
|
29.
|
Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors:
- Atkins, Frank
- Garcia, Carlos
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
All authors: - Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
|
|
30.
|
|
|
31.
|
Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri
- Kulkarni, Kanchan
- Orquiza, Michael D
- Schneider, Mark
- Wartofsky, Leonard
Year: 2013
Department:
- Department of Medicine/Endocrinology
- Department of Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L
|
|
32.
|
Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer with suspected bone metastases. MedStar authors:
- Burman, Kenneth D
- Garcia, Carlos
- O'Neil, Jeffrey
- Orquiza, Michael D
- Schneider, Mark
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wexler, Jason
Year: 2013
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
All authors: - Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L
|
|
33.
|
Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with differentiated thyroid cancer with suspected bone metastases MedStar authors:
- Burman, Kenneth D
- Garcia, Carlos
- O'Neil, Jeffrey
- Orquiza, Michael D
- Schneider, Mark
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wexler, Jason
Year: 2013
Institution: - MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L
|
|
34.
|
Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors:
- Atkins, Francis
- Burman, Kenneth D
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Moreau, Shari
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L
|
|
35.
|
Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx) MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri
- Kulkarni, Kanchan
- Orquiza, Michael D
- Schneider, Mark
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2013
Institution: - MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
|
|
36.
|
Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D
|
|
37.
|
Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors:
- Atkins, Francis
- Burman, Kenneth
- Garcia, Carlos
- Khorjekar, Gauri R
- Mete, Mihriye
- Moreau, Shari
- O'Neil, Jeff
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Citation: - Thyroid. 24(9):1394-9, 2014 Sep.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L
|
|
38.
|
Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
|